Exchange: OTC·Updated 03:59 PM EDT

CYDY CytoDyn Inc

$0.2137
$0.0037
(1.76%)
Today
EarningsOct 8
Mkt Cap$306.91M
Vol900,060.00

About CYDY

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development and potential commercialization of its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its current clinical development activities focus on solid-tumor oncology, including colorectal cancer and metastatic triple-negative breast cancer, and the development of a long-acting version of leronlimab. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
54

Neutral Sentiment

How do you feel about CYDY?

Advertisement|Remove ads.